Insight

Research & Development Performance

How to spot leaders vs. laggards

Jeff Stoll

Jeff Stoll

Principal, National Strategy Life Sciences Leader, KPMG US

+1 617-988-1000

Alasdair Milton, PhD

Alasdair Milton, PhD

Managing Director, Healthcare and Life Sciences Strategy, KPMG US

+1 617-988-5419

Brian Tam

Brian Tam

Director Advisory, Strategy, KPMG US

+1 617-988-1000

An external view of biopharma's R&D performance has resulted in unclear responses to a seemingly basic question: Has the industry improved or declined over the last decade? Market reports assert conflicting messages as definitions and measure of performance vary. This paper evaluates the heart of the industry's mission and the leading indicator of long-term success: R&D performance.